Literature DB >> 28057135

[A cohort study of hepatitis B virus carriers progressing to chronic hepatitis in Jiangsu province, 2012-2014].

L G Zhu1, J Jiang1, C Song2, Y Zou3, J F Xu4, H J Liu5, H Peng1, Z B Hu6, F C Zhu1, H B Shen2, X J Zhai1.   

Abstract

Objective: To understand epidemiological characteristics and influencing factors of hepatitis B virus (HBV) carriers progressing to chronic hepatitis B in Jiangsu, and provide evidence for regular management of HBV carriers.
Methods: From 2012 to 2014, a cohort study was conducted among the HBV carriers in an area in Jiangsu province. Association between HBV carriers' demographics, HBeAg level and HBV DNA detection result and incidence of chronic hepatitis B was analyzed by Cox regression analyses.
Results: In 2012, a total of 4 069 HBV carriers aged (52.0±12.8) years were surveyed. By 2014, chronic hepatitis B had developed in 1 444 cases, with the rate of 21.0/100 person-years. Cox regression analysis indicted that, in addition to gender, HBV DNA level was an important influencing factor for the incidence of chronic hepatitis B (P<0.05). In HBeAg positive carriers progressing to chronic hepatitis, 40.7% had HBeAg seroconversion, and reversion of HBeAg occurred in 1.7% of HBeAg negative carriers.
Conclusion: Chronic hepatitis B developed in more than 1/5 (21.0/100 person-years) of HBV carriers in the surveyed area in Jiangsu. It is suggested to conduct regular ALT, HBV DNA detection and B ultrasonic examination in HBV carriers for the early detection of chronic hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28057135     DOI: 10.3760/cma.j.issn.0254-6450.2016.11.006

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  1 in total

1.  Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.

Authors:  Liguo Zhu; Jie Jiang; Xiangjun Zhai; Aileen Baecker; Hong Peng; Jiao Qian; MingHao Zhou; Ci Song; Yan Zhou; Jianfang Xu; Hongjian Liu; Dong Hang; Zhibin Hu; Hongbin Shen; Zuo-Feng Zhang; Fengcai Zhu
Journal:  Liver Int       Date:  2018-08-19       Impact factor: 5.828

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.